Surgery and interventional radiology in the treatment of liver cancer

Cover Page

Cite item

Full Text

Open Access Open Access
Restricted Access Access granted
Restricted Access Subscription or Fee Access

Abstract

The treatment results of more than 800 patients with primary and metastatic liver malignancies including 120 with hepatic resections are analyzed in comparison with the literature data. Modern tendencies in the tactics of management for liver tumors are reviewed. It is noted that curable liver resection is still the main surgical procedure in liver malignancies. Re-resection has become a routine intervention but is possible in less than 20 per cent of patients. In the last years, liver transplantation appears as an alternative curable treatment of hepatocellular carcinoma. There is improvement of results of «debulking» surgical procedures combined with locoregional chemotherapy. No positive effects of preoperative arterial infusion or chemoembolization for resectable liver tumors were found. On the other hand, preoperative portal vein embolization is widely used for decreased risk of postoperative hepatic failure. The efficacy of adjuvant arterial and portal vein chemotherapy is not fully proven. Periodical hepatic artery and portal vein chemoembolizations appear to be effective for this purpose. Combination of regional chemotherapy and local ablation (ethanol injection, radiofrequency, laser, cryosurgery) are reasonable for the management of unresectable recurrent liver cancer. It is concluded that multimodality approach including methods of surgery and interventional radiology should be preferred for hepatic malignancies. Use of this approach improves treatment results.

About the authors

A. M. Granov

Central Research Roentgenoradiological Institute

Author for correspondence.
Email: shabanov@mail.rcom.ru

Академик РАМН

Russian Federation, St. Petersburg

P. G. Tarazov

Central Research Roentgenoradiological Institute

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

D. A. Granov

Central Research Roentgenoradiological Institute

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

V. N. Polyssalov

Central Research Roentgenoradiological Institute

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

A. A. Polikarpov

Central Research Roentgenoradiological Institute

Email: shabanov@mail.rcom.ru
Russian Federation, St. Petersburg

References

  1. Вишневский В. А., Чжао А. В., Мухаммад М. Хирургическая тактика при метастатическом поражении печени (обзор литературы) // Хирургия. 1998. № 4. С. 57-61.
  2. Гранов А. М., Таразов П. Г., Гранов Д. А. Интервенционная радиология в комбинированном хирургическом лечении рака печени // Вопр. онкол. 2002. Т. 48. № 4-5. С. 480-488.
  3. Гранов Д. А., Таразов П. Г. Рентгеноэндоваскулярные вмешательства в лечении злокачественных опухолей печени. СПб.: Фолиант, 2002.
  4. Патютко Ю. И., Ибрагимов С. С., Лагошный А.Т. и др. Диагностика и хирургическое лечение метастатических опухолей печени // Вестник хирургии. 1994. № 7-12. С. 10-14.
  5. Старинский В. В., Петрова Г В., Чиссов В. И. и др. Заболеваемость населения России злокачественными новообразованиями в 2000 г. // Рос. онкол. журн. 2002. № 3. С. 39-44.
  6. Таразов П. Г Предоперационная артериальная химиоэмболизация при злокачественных опухолях печени (обзор литературы) // Вестник хирургии. 2001. № 3. С. 119-123.
  7. Arii S., Tanaka J., Fujita К. et al. A retrospective study of the preventive effect of transarterial chemotherapy for intrahepatic recurrence of hepatocellular carcinoma after partial hepatectomy // J. Hep. Bil. Pancr. Surg. 1994. Vol. 1. № 3. P. 263-266.
  8. Belli G., lanelli A., Romano G., Marano I. Hepatic resection and percutaneous ethanol injection for the treatment of selected patients with more than one hepatocellular carcinoma // Eur. J. Surg. 1999. Vol. 165. № 7. P. 647-651.
  9. Biasco G., Gallerani E. Treatment of liver metastases from colorectal cancer: What is the best approach today? // Dig. Liver Dis. 2001. Vol. 33. № 5. P. 438-444.
  10. Durand F, Belghiti J. Liver transplantation for hepatocellular carcinoma // Hepatogastroenterology. 2002. Vol. 49. № 43. P. 47-52.
  11. Fong Y. Surgical therapy of hepatic colorectal metastases: Review // CA-A Cancer J. Clin. 1999. Vol. 49. № 4. P. 231-25 5.
  12. Gouillat C., Manganas D., Saguier G. et al. Resection of hepatocellular carcinoma in cirrhotic patients: Longterm results of a prospective study // J. Amer. Coll. Surg. 1999. Vol. 189. № 3. P. 282-290.
  13. Okuno K., Shigeoka H., Lee Y. S. et al. Adjuvant hepatic arterial IL-2 and MMC, 5-FU after curative resection of colorectal liver metastases // Hepatogastroenterology. 1996. Vol. 43. № 9. P. 688-691.
  14. Poon R. T. P., Fan S. T., Wong J. Risk factors, prevention, and management of postoperative recurrence after resection of hepatocellular carcinoma: Review // Ann. Surg. 2000. Vol. 232. № 1. P. 10-24.
  15. Wanebo H. J., Chu Q. D., Avradopoulos K. A., Vezeridis M. P Current perspectives on repeat hepatic resection for colorectal carcinoma: A review // Surgery. 1996. Vol. 119. №4. P. 361-371.
  16. Weimann A., Varnholt H., Schlitt H. J. et al. Retrospective analysis of prognostic factors after liver resection and transplantation for cholangiocellular carcinoma // Brit. J. Surg. 2000. Vol. 87. № 9. P. 1182-1187.
  17. Zhou X. D., Tang Z. Y, Yang В. H. et al. Experience in 1000 patients who underwent hepatectomy for small hepatocellular carcinoma // Cancer. 2001. Vol. 91. № 8. P. 1479-1486.

Supplementary files

Supplementary Files
Action
1. JATS XML

Copyright (c) 2003 Eco-Vector



СМИ зарегистрировано Федеральной службой по надзору в сфере связи, информационных технологий и массовых коммуникаций (Роскомнадзор).
Регистрационный номер и дата принятия решения о регистрации СМИ: серия ПИ № ФС 77 - 74760 от 29.12.2018 г.